Ridgeback Capital Investments L.P. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:14 pm Sale | 2021-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ridgeback Capital Investments L.P. | 0 0.000% | -1,252,250 (Position Closed) | Filing |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ridgeback Capital Investments L.P. | 1,252,250 5.200% | 1,252,250 (New Position) | Filing |